Capability details
Adial Pharmaceuticals, LLC engages in the development of prescription medications for addiction and related disorders. The company's research pipeline includes AD04, a compound that completed Phase IIb study for the treatment of alcohol use disorders; and AD01, which completed Phase I clinical-stage for treating addictive behaviors.